Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,531.00 1.00 (0.07%)

Bid:

1,531.00

Ask:

1,532.00

Spread: 1.00 (0.065%)

Market Cap: £3.22b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Thursday broker round-up

Thu, 02nd Apr 2020 13:03

(Sharecast News) - Unilever: Barclays upgrades to equal weight with a target price of 4,420p.

Frontier Developments: Berenberg reiterates buy with a target price of 1,800p.

AJ Bell: Berenberg reiterates sell with a target price of 230p.

Eurocell: Canaccord reiterates buy with a target price of 275p.

Admiral Group: Barclays reiterates overweight with a target price of 2,376p.

Intercontinental Hotels: Deutsche Bank upgrades to buy with a target price of 4,600p.

Whitbread: Deutsche Bank reiterates hold with a target price of 3,340p.

Rolls-Royce: UBS downgrades to neutral with a target price of 328p.

Royal Dutch Shell: Liberum reiterates buy with a target price of 2,000p.

Burford Capital: Liberum reiterates buy with a target price of 2,600p.

Meggitt: Credit Suisse reiterates underperform with a target price of 270p.

Vodafone: Credit Suisse reiterates outperform with a target price of 170p.

Smiths (DS): JP Morgan upgrades to buy with a target price of 325p.

Hikma: JP Morgan upgrades to overweight with a target price of 2,400p.

Daily Mail: Citigroup reiterates sell with a target price of 625p.

WPP: Citigroup reiterates buy with a target price of 1,050p.